Understanding how biologic treatments affect severe asthma in minority patients
Synthesizing Trial and Real-world Data on the Use of Biologics in Patients with Severe Asthma
This study is looking at how well biologic treatments work for people with severe asthma, especially focusing on African-American and Puerto Rican patients, to better understand their thoughts and experiences with these therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10996196 on NIH RePORTER |
What this research studies
This research investigates the use of biologic therapies in patients with severe asthma, particularly focusing on African-American and Puerto Rican populations who experience higher rates of asthma-related issues. The study aims to gather real-world data and patient perspectives on biologics, exploring their attitudes and beliefs about these treatments. By employing mixed methods and analyzing various patient and provider factors, the research seeks to understand how these elements influence the effectiveness and utilization of biologics in these communities.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with severe asthma, particularly those who identify as African-American or Puerto Rican.
Not a fit: Patients with mild asthma or those who do not belong to the targeted minority groups may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved asthma treatment strategies that are more effective for minority patients.
How similar studies have performed: Previous research has shown that addressing disparities in treatment can lead to improved health outcomes, suggesting that this approach has potential for success.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Akenroye, Ayobami T — Brigham and Women's Hospital
- Study coordinator: Akenroye, Ayobami T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.